Thinq Pharm-cro Pvt Company Profile
✉ Email this page to a colleague
What is the competitive landscape for THINQ PHARM-CRO PVT, and what generic and branded alternatives to THINQ PHARM-CRO PVT drugs are available?
THINQ PHARM-CRO PVT has six approved drugs.
Summary for Thinq Pharm-cro Pvt
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 6 |
Drugs and US Patents for Thinq Pharm-cro Pvt
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Thinq Pharm-cro Pvt | TINIDAZOLE | tinidazole | TABLET;ORAL | 202489-001 | Oct 9, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Thinq Pharm-cro Pvt | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | TABLET;ORAL | 210228-001 | Aug 30, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Thinq Pharm-cro Pvt | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 207613-002 | Nov 2, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Thinq Pharm-cro Pvt | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | TABLET;ORAL | 210250-001 | Aug 30, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
